ThomasNGeorgeMD

Director, Neonatology Children’s Minnesota Professor, Pediatrics, University of Minnesota

Dr. George is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
2525 Chicago Ave
Minneapolis, MN 55404
Phone+1 612-813-6295

Fax+1 612-624-8176

University of Iowa Hospitals and ClinicsFellowship, Neonatal-Perinatal Medicine, 1994 - 1997
University of Iowa Hospitals and ClinicsResidency, Pediatrics, 1991 - 1994
Indiana University School of MedicineClass of 1991

PubMed

245 citations
Early Inhaled Nitric Oxide Therapy in Premature Newborns with Respiratory Failure
John Kinsella, Gary Cutter, William F. Walsh, Dale R. Gerstmann, Carl L. Bose
The New England Journal of Medicine. 2006-07-27
6 citations
Association between Term Equivalent Brain Magnetic Resonance Imaging and 2-Year Outcomes in Extremely Preterm Infants: A Report from the Preterm Erythropoietin Neuropr...
Dennis E. Mayock, Semsa Gogcu, Mihai Puia-Dumitrescu, Dennis W. W. Shaw, Jason N. Wright
The Journal of Pediatrics. 2021-08-26
10 citations
Variation in the Phototherapy Practices and Irradiance of Devices in a Major Metropolitan Area.
Amy R Borden, Katie Satrom, Paul Wratkowski, Thomas N. George, Constance A Adkisson
Neonatology. 2018-01-01

Lectures

NSABP FR-2: Phase II study of durvalumab following neoadjuvant chemoRT in stage II-IV rectal cancer.
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
Phase II trial of the PARP inhibitor, niraparib, in BAP1 and other DNA damage response (DDR) pathway deficient neoplasms including cholangiocarcinoma.
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020